<DOC>
	<DOCNO>NCT01493089</DOCNO>
	<brief_summary>Heartburn main symptom Gastroesophageal Reflux Disease ( GERD ) , , accompany acid regurgitation symptom , substantial negative impact patient ' quality life . Although number treatment option available , effective therapy still require . The failure proton pump inhibitor ( PPIs ) completely resolve symptom accept problem , approximately 25 % patient GERD continue experience symptom heartburn spite treatment . This study aim demonstrate earlier onset relief symptom patient suffer heartburn associate GERD use immediate-release omeprazole/sodium bicarbonate formulation compare delayed-release omeprazole ( Losec® ) .</brief_summary>
	<brief_title>Phase III Study Comparing Zegerid® With Losec® Relief Heartburn Associated With Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Omeprazole , sodium bicarbonate drug combination</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Study patient include study satisfy follow criterion : 1 . Male female , 18 75 year old . 2 . History frequent episode heartburn associate GERD least 2 3 day per week 24 week screen respond standard PPI therapy past 12 month . 3 . Have take ondemand PPI therapy &gt; 3 consecutive day within 4 week screen period . 4 . The patient 's write informed consent must obtain prior inclusion . 5 . Willing able complete entire procedure comply study instruction . 6 . Females childbearing potential must employ adequate method birth control . Inclusion criterion applicable Screening period : 1 . Recorded least 1 evaluable episode heartburn 2 separate day level 4 high 9point Likert severity scale ( point 3 08 point scale ) prior randomisation . 2 . Competent use completion ediary . Study patient exclude meet follow criterion : 1 . Age &lt; 18 &gt; 75 year old . 2 . Intake medication purpose eradication Helicobacter pylorus ( H. pylorus ) last 28 day start study . 3 . Intake systemic glucocorticoid nonsteroidal antiinflammatory drug ( NSAIDs ) include COX2inhibitors ( ≥ 3 consecutive day per week ) last 28 day start study ; except regular intake enteric coat aspirin dosage 150 mg/d . 4 . Previously underwent acidlowering surgery surgery oesophagus and/or upper gastrointestinal tract ( exclude : appendectomy , cholecystectomy polypectomy ) . 5 . History coexist disease affect oesophagus ( e.g . Barrett 's oesophagus , ZollingerEllison syndrome , oesophageal stricture ) , undergone endoscopy result incomplete heal erosion follow standard PPI therapy within last 3 month . 6 . History active gastric duodenal ulcer within 3 month first dose study drug acute upper gastrointestinal ( GI ) bleeding within last 6 month . 7 . Documented presence severe renal hepatic insufficiency . 8 . Known hypersensitivity omeprazole . 9 . Concurrent participation study investigational drug participation within 30 day study entry . 10 . Females pregnant , planning pregnancy . Females child bear potential use reliable method birth control . 11 . Clinically significant laboratory abnormality disease , opinion Investigator , create risk patient , obscure effect study treatment interfere study result . 12 . Received require follow drug within 2 week first dose study continue need drug concurrent therapy : theophylline , bismuth salt , warfarin , phenytoin , tacrolimus , diazepam , cyclosporine , disulfiram , benzodiazepine , barbiturate , antineoplastic agent , erythromycin , clarithromycin , sucralfate , clopidogrel protease inhibitor . 13 . Taking concomitant medication rely presence gastric acid optimal bioavailability ( e.g . ketoconazole , ampicillin ester iron salt ) . 14 . Onset psychoactive medication ( e.g . depressant , stimulant hallucinogen ) previous 6 month entire course study . Exclusion criterion applicable Screening period : 1 . Recorded &lt; 1 episode heartburn 2 separate day level 4 9 point Likert severity scale ( point 3 08 point scale ) 7 day screen period prior randomisation 2 . Completing &lt; 90 % ( &lt; 9 10 ) time point evaluable data e diary .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>